... on the recuperation of Indian pharma ancillary industry post-Covid-19 lockdown. Q: How do you see the recovery in the pharma ancillary industry such as that ... Rishabh Bindlish: With many industries/products not falling under the ...
Read more: Financial pressure has intensified for the pharma ancillary players: Rishabh Bindlish